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The Plk1-dependent Phosphoproteome of the
Early Mitotic Spindle*□S
Anna Santamaria,a,b,c,h Bin Wang,a,b,d Sabine Elowe,a,b,e Rainer Malik,a,f Feng Zhang,a,g
Manuel Bauer,h Alexander Schmidt,h Herman H. W. Sillje´,a,i Roman Ko¨rner,a,j
and Erich A. Nigga,h
Polo-like kinases regulate many aspects of mitotic and
meiotic progression from yeast to man. In early mitosis,
mammalian Polo-like kinase 1 (Plk1) controls centro-
some maturation, spindle assembly, and microtubule
attachment to kinetochores. However, despite the es-
sential and diverse functions of Plk1, the full range of
Plk1 substrates remains to be explored. To investigate
the Plk1-dependent phosphoproteome of the human mi-
totic spindle, we combined stable isotope labeling by
amino acids in cell culture with Plk1 inactivation or deple-
tion followed by spindle isolation and mass spectrometry.
Our study identified 358 unique Plk1-dependent phos-
phorylation sites on spindle proteins, including novel sub-
strates, illustrating the complexity of the Plk1-dependent
signaling network. Over 100 sites were validated by in
vitro phosphorylation of peptide arrays, resulting in a
broadening of the Plk1 consensus motif. Collectively, our
data provide a rich source of information on Plk1-depen-
dent phosphorylation, Plk1 docking to substrates, the in-
fluence of phosphorylation on protein localization, and the
functional interaction between Plk1 and Aurora A on the
early mitotic spindle. Molecular & Cellular Proteomics
10: 10.1074/mcp.M110.004457, 1–18, 2011.
During mitosis, multiple processes, such as mitotic entry,
spindle assembly, chromosome segregation, and cytokinesis,
must be carefully coordinated to ensure the error-free distri-
bution of chromosomes into the newly forming daughter cells.
The physical separation of the chromosomes to opposite
poles of the cell is driven by the mitotic spindle, a proteina-
ceous and highly dynamic microtubule (MT)1-based macro-
molecular machine. Spindle assembly begins early in mitosis
and is completed when the bipolar attachment of microtu-
bules to kinetochore (KT) pairs is achieved (1, 2). Polo-like
kinase 1 (Plk1), a serine/threonine-specific kinase first identi-
fied in Drosophila (3), is one of the key regulators of this
essential mitotic process and has therefore attracted much
attention (4–6). In agreement with its diverse functions, the
localization of Plk1 during mitosis is dynamic. Plk1 first asso-
ciates with centrosomes in prophase before it localizes to
spindle poles and KTs in prometaphase and metaphase. Dur-
ing anaphase, Plk1 is recruited to the central spindle and
finally accumulates at the midbody during telophase. Pro-
teomics studies using oriented peptide libraries have
shown that two so-called polo boxes at the C-terminal end of
Plk1, the polo box domain (PBD), are crucial for the localiza-
tion of this kinase to cellular structures (7, 8). This domain
binds to specific phosphorylated sequence motifs that are
created by other priming kinases or are self-primed by Plk1
itself, thus providing an efficient mechanism to regulate local-
ization and substrate selectivity in time and space (9–11).
Despite the pleiotropic and critical functions of Plk1 during
mitosis, only a limited number of target proteins and phos-
phorylation sites on substrates have so far been identified or
studied in detail (4–6, 12). The difficulties in identification of
bona fide Plk1 substrates stem from the low abundance of
some substrates, technical limitations for determining in vivo
phosphorylation sites, the requirement for Plk1 localization for
recognition of some substrates, and the possibility that Plk1
may phosphorylate a broader consensus motif than deter-
mined previously (13). Recent developments in mass spec-
trometry (MS)-based proteomics have allowed the identifica-
tion of a large number of in vivo phosphorylation sites from
complex samples (14). However, the nature of the kinase(s)
responsible for most of these phosphorylation events is still
unclear, and the assignment of phosphorylation sites to indi-
vidual kinases remains a challenging task. Previously, we
explored the human mitotic spindle by MS and successfully
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identified a large number of novel spindle proteins and phos-
phorylation sites (15, 16). Now, the development of quantita-
tive methods to monitor in vivo phosphorylation changes in
complex samples (17–19) represents a unique opportunity to
address the role of individual kinases in spindle function.
To study Plk1 function at the mitotic spindle, we combined
quantitative proteomics using stable isotope labeling by
amino acids in cell culture (SILAC) (20) with the isolation of
human mitotic spindles and phosphopeptide enrichment. To
expand the experimental coverage of Plk1 substrates and
gain further insight into direct and indirect functions of Plk1,
we compared the phosphoproteomes of mitotic spindles iso-
lated from cells lacking Plk1 activity with spindles from cells
with fully active kinase. Two independent approaches were
used to interfere with Plk1 activity: protein depletion using an
inducible small hairpin (shRNA) cell line and selective inhibi-
tion of the kinase by the small molecule inhibitor ZK-thiazo-
lidinone (TAL) (21). Phosphorylation sites found to be down-
regulated after Plk1 inhibition/depletion were subsequently
validated using in vitro phosphorylation of synthetic peptide
arrays. This approach identified many candidate Plk1 sub-
strates, allowed confirmation of direct phosphorylation by
Plk1 of more than 100 sites identified in vivo, and suggested
a broader phosphorylation consensus motif for this kinase.
Collectively, our data set provides a rich resource for in-depth
studies on the spindle-associated Plk1-dependent phospho-
proteome. This is illustrated by selective follow-up studies in
which we validated the Plk1-dependent localization of sub-
strates to centrosomes and kinetochores. In particular, using
a phosphospecific antibody, we confirmed Plk1-dependent
CENP-F phosphorylation in vivo and demonstrated that
CENP-F localization to kinetochores depends on Plk1 kinase
activity. Furthermore, we identified several Aurora A-depen-
dent phosphorylation events that are regulated by Plk1, sup-
porting the emerging view of an intimate functional relation-
ship between Plk1 and Aurora A kinase (22, 23).
EXPERIMENTAL PROCEDURES
Cell Culture, SILAC Media, Synchronization, and Spindle Isola-
tion—For SILAC, HeLa S3 cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) deficient in amino acids arginine and lysine
and supplemented with 5% dialyzed FCS, 100 units/ml penicillin, 100
g/ml streptomycin, and either unlabeled arginineHCl and lysineHCl




HCl (SILAC heavy) (Cambridge Isotope Laboratories) at concentra-
tions of 42 (arginine) and 72 g/ml (lysine). Cells were grown at 37 °C
in a humidified incubator with 5% atmospheric CO2. Cells were adapted
to the appropriate SILAC medium for at least six passages to achieve
complete incorporation of the isotope-labeled amino acids. For large
scale mitotic spindle isolation, each population of HeLa S3 labeled cells
was propagated to five triple flasks with a total surface of 500 cm2. Cells
were first presynchronized with thymidine (2 mM) for 20 h, then washed
twice with PBS, and released from the thymidine block into TAL or
monastrol (MA)-containing medium (1 or 150 M, respectively) or by
induction with 1 g/ml tetracycline for 36 h in the case of the inducible
cell lines. Taxol-stabilized mitotic spindles (including kinetochores and
centrosomes) were isolated as described previously (24).
In-gel Protein Digestion—Enriched spindle proteins were sepa-
rated by SDS-PAGE and in-gel (25) digested with trypsin. In each
experiment, about 400 g of the spindle fraction was loaded to one
NuPAGE Bis-Tris gel and run for 50 min using a 200-V/100-mA
program. Gels were stained with a 1:1 mixture of 0.2% Coomassie
Blue in methanol (MeOH) and 20% acetic acid for 40 min and
destained using a mixture of 30% MeOH and 10% acetic acid for 15
min, 10% acetic acid for 1 h, and 2% acetic acid overnight at 4 °C.
Gels were cut into 20 slices each. After reduction and alkylation,
proteins were digested by 15 ng/l trypsin for 16 h. Digested peptides
were extracted with 30% ACN and 5% formic acid and dried.
Phosphopeptide Enrichment and Desalting—Phosphorylated pep-
tides were selectively enriched by titanium dioxide beads with lactic
acid as a modifier (26). A piece of C8 material was plugged at the
constricted end of a GELoader tip, and about 3 mg of titanium dioxide
beads was transferred to each of the microcolumns. The microcol-
umns were washed with 40 l of 0.3 g/l lactic acid in a mixture
of 80% ACN and 0.2% TFA. Digested peptides were redissolved in
0.3 g/l lactic acid in a mixture of 80% ACN and 2% TFA and
applied to microcolumns with a slow flow rate, allowing phosphor-
ylated peptides to bind to the titanium dioxide beads. The micro-
columns were subsequently washed with 40 l of 0.3 g/l lactic
acid in a mixture of 80% ACN and 0.2% TFA and 40 l of a mixture
of 80% ACN and 0.2% TFA. Phosphorylated peptides were eluted
with 40 l of 0.6% NH4OH and 40 l of a mixture of 80% ACN and
0.2% TFA. The eluates were dried and redissolved in 0.5% formic
acid for LC-MS/MS analysis. The flow-through fractions were de-
salted with C18 reversed-phase material prior to LC-MS/MS for
protein expression level measurement. Briefly, a piece of C18 ma-
terial was plugged into a GELoader tip and washed with 20 l of
2-propanol and 20 l of 5% formic acid. The dried flow-through
fractions were redissolved in 20 l of 5% formic acid and applied to
the C18 microcolumns. The columns were then washed with 20 l of
5% formic acid, and subsequently peptides were eluted with 2  20
l of 50% methanol and 2% formic acid. The eluates were dried
and redissolved in 0.5% formic acid for LC-MS/MS.
Nano-LC-MS/MS Analysis—The nano-LC-MS/MS analysis was
performed with a nanoACQUITY ultraperformance liquid chromatog-
raphy (UPLC) system (Waters) connected to a hybrid linear ion trap/
orbitrap tandem mass spectrometer (Thermo Electron). Dissolved
peptides were loaded at 500 nl/min into a pulled and fused silica
capillary with an inner diameter of 75 m and a tip of 8 m (New
Objective) packed to a length of 12 cm with reversed-phase ReproSil-
Pur C18-AQ 3-m resin (Maisch) and eluted at 200 nl/min by a
stepwise 180-min gradient of 0–100% buffer A (0.2% formic acid in
water) and buffer B (0.2% formic acid in acetonitrile). The linear ion
trap/orbitrap (LTQ-Orbitrap) mass spectrometer was operated in a
data-dependent MS/MS mode. Survey full-scan MS spectra (from
m/z 300 to 2000) were acquired in the orbitrap with a resolution of
60,000 at m/z 400. A maximum of five peptides were sequentially
isolated for fragmentation in the linear ion trap using collision-induced
dissociation (CID). The lock mass option was enabled to improve
mass accuracy as described (27). All spectra were acquired with
Xcalibur software.
Data Processing and Analysis—MS spectra were searched via
MASCOT (28) (version 2.2.0, Matrix Science, London, UK). Searches
were performed against the International Protein Index (IPI) human
(version 3.48; 71,400 protein entries) database that was concatenated
with decoy database sequences (142,800 protein entries in total) (29).
Peak lists were generated using MaxQuant (30) (version 1.0.12.5) with
the following parameters: top six MS/MS peaks for 100 Da, three data
points for centroid, Gaussian centroid determination, slice peaks at
local minima. MaxQuant identifies potential SILAC pairs based on
characteristics such as mass differences of labeled amino acids and
Plk1-selective Proteomics
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intensity correlation over elution time to establish peptide peak lists.
MaxQuant was also used for SILAC quantitation, false discovery rate
(FDR) determination, peptide/protein grouping, phosphorylation site
localization probability scoring, and data filtering based on MASCOT
search results. The initial precursor mass tolerance was set to 7
ppm, whereas an accuracy of 0.5 Da was used for MS/MS frag-
mentation spectra. Enzyme specificity was set to trypsin, allowing
cleavages N-terminal to proline. Carbamidomethylation was set as
fixed modification. Oxidation, protein N-terminal acetylation, Arg10,
Lys8, and phosphorylation (Ser/Thr/Tyr) were considered as variable
modifications. A maximum of three labeled amino acids and two
missed tryptic cleavages and a minimum peptide length of six amino
acids were allowed. A minimum of one unique peptide was required
for protein identification. In the case where the set of identified pep-
tides in one protein was equal to or completely contained in the set of
identified peptides of another protein, these two proteins were joined
in the same protein group. Shared peptides are most parsimoniously
associated within the group of the protein with the highest number of
identified peptides but remain in all groups where they occur (30). The
protein with the highest number of identified peptides is presented as
the leading protein in the supplemental tables with the highest con-
fidence in its protein group. To ensure the fidelity of protein and
phosphorylation site identifications, the target-decoy database strat-
egy was used to minimize FDRs in our data set (29). A composite
database is created by a “target” protein sequence database appro-
priate to the protein mixture to be analyzed (IPI human version 3.48),
and a “decoy” database is created by reversing the target protein
sequences. Because the reverse transformation preserves amino acid
frequencies, protein and (approximate) peptide length distributions,
and approximate mass distributions of theoretical peptides, the num-
ber of spectra matching decoy sequences gives an estimate of FDR.
Estimated peptide/protein FDR was calculated as follows: (Number of
hits in the reversed database/Number of hits in the forward data-
base) 100% (31). A maximum 5% peptide FDR and 2% protein FDR
were allowed for the first step peptide/protein identification. A
MASCOT ion score of at least 12 and phosphorylation site localization
probability equal to or higher than 75% were used for data filtering.
However, we included in a separate table (supplemental Ta-
ble S5, A and B) all down-regulated phosphorylation sites (see below)
with lower MASCOT scores (7  x  12) identified from inhibitor
(supplemental Table S5A) and shRNA (supplemental Table S5B)
experiments as some of these sites might also be functionally relevant
and may be considered for validation by in vitro spotting experiments
(see below) despite their lower confidence. Automated quantitation
was accomplished by the MaxQuant software. To correct for possible
changes of protein levels on the mitotic spindle, the SILAC ratio of
each phosphorylated peptide was normalized to the SILAC ratio of
the corresponding protein (calculated as the mean of all unmodified
peptide ratios from this protein).
To compare the protein levels on isolated spindles with those in
total lysates by MS (see Fig. 5A), ratios (H/L: TAL/MA) on the spindle
were normalized against the average ratio of all /-Tubulin subunits
identified to correct for variability in spindle isolation (supple-
mental Table S4A). Next, the ratios from the two spindle experiments
(biological replicates) were averaged, and proteins with ratios that
followed a different trend between biological replicates were ex-
cluded (above and below 1  0.2). To define the relative change in
spindle localization, the averaged normalized ratio for each protein
from the spindle preparation experiment was divided by the corre-
sponding normalized ratio from total lysates.
The orbitrap raw data (MS raw files), MS/MS peak lists, and
MS/MS spectra associated with this study were submitted to the
Tranche data repository and can be downloaded from https://




Bioinformatics—Motif-X was used with a significance cutoff of
0.0001 and at least 10 occurrences of the motif in the set. IPI human
was used as a background data set with the built-in function. STRING
8.0 was queried with human protein symbols from supplemen-
tal Table S2, A and B. Confidence was set to medium (0.400), and
only options “Databases” and “Experiments” were selected. Conser-
vation of phosphorylated residues was checked with BLAST searches
against rat (RGSC3.4.54), mouse (NCBIM37.54), zebrafish (Zv8.54),
Drosophila melanogaster (BDGP5.4), Xenopus tropicalis (JGI4.1.54),
Caenorhabditis elegans (WS190.54), and Saccharomyces cerevisiae
(SGD1.0) proteomes obtained from the Ensembl FTP server. First,
close sequence homologs of the proteins were identified using an
E-value cutoff of 1e50. Then, the phosphorylated site was checked
for exact conservation in the alignment.
Peptide Spot Array Synthesis and Phosphorylation Assay—Peptide
arrays were constructed using standard Fmoc (N-(9-fluorenyl)me-
thoxycarbonyl) chemistry on a MultiPep robotic spotter according to
the manufacturer’s directions (Intavis). For Plk1 assays on peptide-
immobilized cellulose membranes, dried membranes were first
washed in ethanol and then hydrated in kinase buffer (50 mM Tris-HCl,
pH7.5, 10 mM MgCl2, 1 mM DTT, 100 M NaF, and 10 M sodium
orthovanadate) for 1 h followed by overnight blocking in kinase buffer
with 100 mM NaCl and 0.5 mg/ml BSA. The next day, the membrane
was blocked again with kinase buffer containing 1 mg/ml BSA, 100
mM NaCl, and 10 M cold ATP at 30 °C for 45 min. The block was
subsequently replaced with kinase reaction buffer containing 0.2
mg/ml BSA, 50 Ci/ml [-32P]ATP (3000 Ci/mmol, 10 mCi/ml), 150 nM
recombinant His-Plk1, and 10 M ATP for 3 h on a shaker at 30 °C.
The membranes were then washed extensively (10  15 min in 1 M
NaCl, 3 5 min in H2O, 3 15 min 5% H3PO4, and 3 5 min in H2O)
and then sonicated overnight in 8 M urea, 1% SDS (w/v), and 0.5%
(v/v) -mercaptoethanol to remove residual nonspecific radioactivity.
The membranes were washed again with H2O followed by ethanol
and dried before being visualized by autoradiography. Aurora A as-
says were performed similarly but using Aurora A kinase buffer (20 mM
Hepes, pH 7.4, 150 mM KCl, 5 mM MnCl2, 5 mM NaF, and 1 mM DTT).
Sites were considered positive when differential signals could be
observed between the Ser/Thr/Tyr and the Ala version of the peptide,
negative when no detectable signal was observed, and non-conclu-
sive when the peptide was also phosphorylated on the membrane
incubated with ATP alone as control or alternatively when the signal
between the Ser/Thr/Tyr and the Ala version of the peptide was
indistinguishable.
RESULTS
Experimental Strategy to Compare Spindle Phosphopro-
teomes in Presence or Absence of Plk1 Activity—To investi-
gate the Plk1-dependent phosphoproteome of human mitotic
spindles, we used a quantitative phosphoproteomics strategy
that combines SILAC with selective enrichment of spindle-
associated proteins. To enable quantitation of the changes of
phosphopeptide abundance by MS, cells were labeled by
growing them in medium containing either normal arginine





(Fig. 1A). To synchronize control cells at a similar mitotic stage
and, importantly, to obtain similar microtubule arrays as in
Plk1-inactivated cells, we interfered with the function of the
Plk1-selective Proteomics
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kinesin motor protein Eg5. Like Plk1 inactivation (32), Eg5
inactivation results in a prometaphase arrest with a monoas-
tral microtubule array surrounded by a ring of chromosomes
(33). Importantly, Plk1 localization and kinase activity were
retained in Eg5-inactivated cells (Figs. 2, A and G, and 6, C
and D; see also supplemental Fig. S1C and “Discussion”) (21),
comparable with prometaphase cells arrested with nocoda-
zole or Taxol (Fig. 2H).
To disrupt Plk1 activity (or Eg5 activity for control), two
experimental strategies were used. First, we interfered with
protein function by lowering protein levels. To this end, we
generated tetracycline (Tet)-inducible stable HeLa S3 cell
lines (shPlk1 and shEg5 for control), allowing the shRNA-
mediated knockdown of Plk1 and Eg5, respectively. After
shRNA induction, Eg5 and Plk1 protein levels were efficiently
reduced when compared with non-induced or control cells (a
stable cell line generated with an empty vector) (Fig. 2, A and
B). As expected, depletion of Plk1 but not Eg5 led to loss of
BubR1 hyperphosphorylation (Fig. 2A), previously shown to
be Plk1-dependent (34–36). Analysis by MS of the protein
levels of Plk1 and Eg5 after Tet induction of the shRNA cell
lines provided an independent assessment for depletion effi-
FIG. 1. Strategies to study Plk1
phosphoproteome on mitotic spin-
dles. A, schematic of the design of
SILAC experiments. HeLa S3 cells
grown in the presence of light or heavy
isotope-labeled arginine and lysine were
subjected to Tet induction or MA/TAL
treatment, respectively. In three experi-
ments, cells for Plk1 or Eg5 inactivation
were grown in light or heavy SILAC me-
dium, respectively, whereas the fourth
experiment (Inhibitor-1) was performed
under a reverse labeling condition. B,
DNA (4-6-diamidino-2-phenylindole,
DAPI staining) is shown for MA- and
TAL-treated cells. C, DNA and spindle
morphology is shown for shEg5- and
shPlk1-induced cells (-Tubulin in
green; DNA in blue). D, DIC pictures of
isolated mitotic spindles from MA/TAL-
treated cells (left panel) and shEg5/
shPlk1-depleted cells (right panel). E,
DIC picture from a single monopolar
spindle from a mixture of MA/TAL-
treated cells. Scale bars, 10 m. F, ana-
lytical strategy to map phosphorylation
sites in spindle proteins. G, validation of
direct Plk1 phosphorylation sites by in
vitro Plk1 kinase assays on peptide ar-
rays. H, flowchart indicating the initial
MaxQuant phosphopeptide output (raw
data) and the subsequent filtering of
candidates, ending with the validation
in vitro: MaxQuant output (supple-
mental Table S1A), Class I phosphoryla-
tion sites identified with MASCOT score
12, quantified sites (with SILAC pair
and normalized against protein ratios),
down-regulated sites, down-regulated
sites on spindle proteins tested in vitro,
and Plk1 and Aurora A sites on spindle
proteins validated in vitro.
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FIG. 2. Establishment of stable inducible shRNA cell lines for Plk1 or Eg5 depletion. A, lysates from control (CTL), shEg5, and shPlk1
cells treated for 36 h with Tet or left for 36 h in Tet-free medium and treated for the last 12 h with nocodazole were used for Western blotting
analysis. Membranes were probed for Eg5, Plk1, BubR1, Cyclin B1, and -Tubulin as loading control. B, shEg5 and shPlk1 cells treated for
36 h with Tet or left for 36 h in Tet-free medium were fixed and stained with the indicated antibodies. Eg5 and Plk1 are shown in green, and
-Tubulin is shown in red. DNA was visualized using DAPI (blue). C and D, mass spectra representing a SILAC peak pair for Plk1 and Eg5,
respectively, from shEg5/shPlk1-induced cells. Note that for Plk1 (C) we could only identify one SILAC unphosphorylated peptide pair. E, FACS
analysis was performed from control, shPlk1, and shEg5 cells treated as in B. The percentage of cells with 2N (G1 and S) or 4N (G2/M) content
Plk1-selective Proteomics
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ciency (Fig. 2, C and D). Flow cytometry (FACS) analysis of
Tet-induced shEg5 or shPlk1 cells revealed an accumulation
of cells with 4N DNA content, indicative of a G2/M arrest (Fig.
2E). Concomitantly, a striking increase in the mitotic index
was observed (Fig. 2F) in agreement with the predominant
phenotype seen upon interference with Plk1 or Eg5 (32, 33).
As a second, complementary approach, we disrupted Plk1
kinase activity using the small molecule inhibitor TAL (21). MA,
a small molecule inhibitor of Eg5 (37), was used to treat
control cells. Both inhibitors are highly specific toward their
targets. TAL showed high selectivity for Plk1 when tested
against a panel of 93 kinases with only two close relatives,
Plk2 and Plk3, displaying significant sensitivity to TAL, and it
produced cellular phenotypes that were indistinguishable
from those caused by other, structurally unrelated Plk1 inhib-
itors (5, 21). MA, on the other hand, was shown to specifically
inhibit Eg5-driven microtubule motility, whereas it had no
effect on processes controlled by other motor proteins (37).
Taxol-stabilized mitotic spindles (containing KTs and cen-
trosomes) were purified essentially as described previously
(24). To ensure minimal variation in sample handling and
processing, equalized amounts of Plk1- and Eg5-depleted/
inhibited cells were combined prior to spindle isolation (Fig. 1,
A–C). Examination of the purified spindles by differential in-
terference contrast (DIC) light microscopy revealed predomi-
nantly monopolar spindles (Fig. 1, D and E), as expected,
largely free of other cellular structures. Purified spindles were
subsequently solubilized and separated by one-dimensional
gradient SDS-PAGE. Gel slices covering the entire protein
mass range were digested with trypsin, and the resulting
peptide fractions were subjected to phosphopeptide enrich-
ment on TiO2 beads. Both TiO2 elution and TiO2 flow-
through fractions (phosphorylated and unphosphorylated
peptides, respectively) were then analyzed using a nano-
LC-ESI orbitrap (Fig. 1F). Two independent experiments
were performed for each Plk1 inhibition strategy, providing
biological replicates (see below). To address the reproduc-
ibility of phosphorylation site identification and quantitation,
samples from one of the experiments performed with the
Tet-inducible stable cell lines were split, separated on dis-
tinct one-dimensional gels, and analyzed as technical rep-
licates. A good reproducibility (r2 value of 0.84) was ob-
served (supplemental Fig. S1A) in line with other
phosphoproteome studies (18, 38).
Plk1-dependent (Phospho)proteome—Data from four inde-
pendent experiments (two experiments performed with small
molecule inhibitors and two performed with shRNA cell lines)
resulted in a total of 3894 unique phosphorylation sites (MAS-
COT score cutoff of 12 (supplemental Table S1, B and C);
Class I sites according to Ref. 17) for which SILAC and protein
ratios could be established. This number included 3092 and
2808 sites from experiments performed with small molecule
inhibitors and the shRNA cell lines, respectively (52% overlap
in identified sites; see supplemental Fig. S2A). Fig. 1H shows
a flowchart of all filtering and experimental validation steps
performed in this study. Detailed information on the numerical
analysis of phosphopeptides and phosphorylation sites is
provided as supplemental information.
To choose optimal thresholds for defining up- and down-
regulated phosphorylation sites, we analyzed a 1:1 mixture of
identically treated but differentially labeled mitotic lysates
(where TAL was applied to both SILAC light and heavy labeled
HeLa S3 cells; see supplemental Fig. S1B). We found that only
1.9% of the detected peptides had SILAC ratios 3/2,
whereas 4.4% were detected with ratios 2/3. According to
the initial SILAC labeling used in the experiments performed
with small molecule inhibitors or shRNA cell lines (i.e. Inhibi-
tor-2 and shRNA experiments; H/L: MA/TAL and Inhibitor-1;
H/L: TAL/MA), the error rate considering the selected thresh-
olds for the down-regulated sites was below 2% in three of
our experiments and around 4% only in one experiment.
Because our work flow included a subsequent in vitro kinase
assay for the verification of potential Plk1 targets, we consid-
ered these error rates as a good compromise between exper-
imental sensitivity and stringency and defined 3/2 and 2/3
(corresponding to signal changes of more than 50%) as
thresholds for up- and down-regulation, respectively. Con-
sistent with this definition, a change of 50% was also consid-
ered significant for regulated phosphorylation events in other
recent SILAC-based phosphoproteomics studies (39–42).
Phosphorylation sites were considered as down-regulated
according to the following criteria. All sites showing contra-
dictory behavior (down-regulated in one experiment but up-
regulated in the biological replicate) were discarded, whereas
sites that were down-regulated in one experiment but un-
changed (ratios between 2/3 and 3/2) or undetectable in the
replicate were retained in the analysis. Data obtained using
the two different strategies, shRNA-mediated depletion or
small molecule-induced inhibition, were analyzed similarly
(supplemental Table S2, A and B). However, in this case, even
contradictory data sets were retained for further biological
analysis. In total, 698 Class I phosphorylation sites in 304
different proteins were down-regulated in at least one of the
four experiments, 525 sites were down-regulated after TAL
is shown. F, mitotic index from control, shEg5, and shPlk1 cells treated for 36 h with Tet or left in Tet-free medium (300 cells for each condition;
n  3). Error bars represent standard deviation. G, DMSO- and MA-treated cells were fixed and stained for the indicated antibodies. Plk1 is
shown in red, and CREST is shown in green. DNA was visualized using DAPI (blue). Scale bars, 10 m. H, Plk1 in vitro kinase assay. Plk1 was
immunoprecipitated from nocodazole-, Taxol-, MA-, TAL-, and MA  TAL-treated cells, and casein was used as substrate. Protein
phosphorylation was visualized by autoradiography of 32P, equal amounts of casein are shown by Coomassie Blue (CB), and immunopre-
cipitates were probed by Western blotting (WB) with anti-Plk1 antibody.
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treatment, and 266 sites were down-regulated after Plk1 de-
pletion by shRNA (supplemental Table S2, A and B, and Fig.
1H; for one example of MS spectra, see supplemen-
tal Fig. S3). In addition, we also evaluated our data using a
“two-standard deviation” cutoff. Filtering the list of 3894 iden-
tified phosphorylation sites using this criterion resulted in a
very similar set of down-regulated phosphorylation sites (709
sites compared with 698 using the 50% change criterion) with
a very high overlap (90.4%), further validating the chosen
cutoff. In our data set, the maximum observed down-regula-
tion (in the protein Nesprin-1) corresponds to ratios of 0.0005
and 0.0027 for inhibitor and shRNA experiments, respectively.
On average, a 2.25-fold change in phosphorylation was ob-
served in the down-regulated phosphorylation sites.
Plk1 Spindle Substrates—We estimate that 101 of the 304
human proteins (33%) with Plk1-dependent phosphorylation
sites identified here have known mitotic spindle functions
(supplemental Table S3, A and B) (15, 16), demonstrating a
substantial enrichment for spindle components in our sam-
ples. In total, 358 phosphorylation sites were down-regulated
on spindle proteins upon Plk1 inactivation either by TAL
treatment or stable shPlk1-mediated depletion (supplemental
Table S3, A and B). In agreement with essential functions of
Plk1 at the spindle poles, phosphorylation sites of centroso-
mal, MT-associated proteins (MAPs), and motor proteins were
identified to be down-regulated upon Plk1 inactivation (Fig.
3A). Among the spindle proteins containing down-regulated
sites, those associated with the centromere or KT structure
were overrepresented, consistent with an important role for
Plk1 in KT function (Fig. 3A). This included the centromeric
protein PBIP1, the protein kinase Bub1, and the subunit of the
chromosomal passenger complex, INCENP, all shown to con-
tribute to KT localization of Plk1 during mitosis (9, 43, 44).
Interestingly, members of the nuclear pore complexes (NPCs),
shown previously to associate with KTs at the onset of mitosis
(45), also exhibited down-regulated sites after Plk1 inhibition
(Fig. 3A). Finally, other mitotic kinases, tubulin subunits, and
proteins functioning in chromosome structure during mitosis
also appeared to be regulated by Plk1. Our data set contained
several known Plk1 substrates, such as Cdc27, INCENP,
Kif20A, and topoisomerase IIA (5, 46), validating our approach
(Fig. 3A).
We also evaluated the set of spindle proteins with down-
regulated sites (supplemental Table S3, A and B) for the
presence of S(pS/pT)P (where pS is phosphoserine and pT is
phosphothreonine) motifs as it has been previously shown
that phosphopeptides bind to the Plk1-PBD through such
motifs (7). Sixty-six of the 101 (65%) spindle proteins with
Plk1-dependent phosphorylation sites contained such a pre-
dicted PBD recognition motif. However, we note that a similar
percentage (62%) of all proteins from the complete human IPI,
when matched for comparable average length, also contained
at least one such potential PBD recognition motif (sup-
plemental Fig. S4A). This suggests that additional features
may be required to rigorously predict a functional PBD in a
full-length Plk1 substrate. Importantly, our study identified the
vast majority (	80%) of spindle proteins carrying both a PBD-
docking site and putative Plk1 phosphorylation site(s) identi-
fied in a previous independent study on Plk1-PBD binding
partners (10). However, only half of these proteins showed
down-regulation at Plk1 phosphorylation sites (supple-
mental Fig. S4B). Interestingly, the other half comprised pro-
teins involved in late mitotic processes, notably Anilin, Rock2,
Septin, and Cdh1, which would suggest an absence of Plk1-
dependent regulation on these proteins during early mitosis.
We also compared our data set with a study on the identifi-
cation of substrates of Cdc5, the budding yeast homolog of
Plk1 (47). However, of the five bioinformatically predicted
substrates validated by chemical genetics, none of the puta-
tive human orthologs exhibited Plk1-regulated phosphoryla-
tion in our study (data not shown).
We also compared the results on the regulation of phos-
phorylation sites as obtained from the two different Plk1 in-
activation strategies. Our data show that chemical inhibition
of Plk1 resulted in a larger number of down-regulated phos-
phorylation sites and a stronger down-regulation at individual
sites than Plk1 depletion (Fig. 3, B and C, supplemen-
tal Fig. S2B, and supplemental Table S3A). Most likely this
reflects both incomplete depletion of Plk1 in the shRNA cell
line and the very potent inhibition of Plk1 achieved by use of
TAL (21). Surprisingly, although the total number of down-
regulated sites identified upon Plk1 depletion was lower,
around half of these were not identified in the TAL-treated
sample (Fig. 3B). This strongly argues in favor of using differ-
ent strategies to interfere with Plk1.
To detect protein-protein networks regulated by Plk1, we
asked whether putative Plk1 substrates were enriched for
members of particular interaction networks using the STRING
database (see supplemental Fig. S5A for complete interaction
network and “Experimental Procedures”). In agreement with
an enrichment of spindle components, two large subnet-
works, including centrosomal as well as a kinetochore and
nuclear pore complex proteins, appeared enriched among
putative Plk1 substrates regardless of the strategy used for
their identification (Fig. 3, D and E). Interaction network anal-
yses were also performed separately for the putative sub-
strates identified through TAL or shPlk1 experiments. Al-
though the analysis of the shPlk1 data set did not reveal
additional subnetworks of apparent functional relevance, in
the group of phosphoproteins down-regulated only upon Plk1
inhibition, we observed two interaction networks containing
ribosome-associated and mRNA-binding proteins (Fig. 3, F
and G). To complete this analysis, we also asked whether
substrates of other members of the Plk family were present
among the phosphoproteins identified in this study. We could
not identify any STRING-predicted interaction partners for
Plk2 or Plk3 in our data set (not shown) but found several
putative Plk4 interaction partners (supplemental Fig. S5B,
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left panel). However, these proteins were also predicted by
STRING to be associated with Plk1 (supplemental Fig. S5B,
right panel). These latter results support the interpretation that
TAL- or shPlk1-induced down-regulation of phosphorylation
on the proteins identified here reflects that action of Plk1
rather than any other Plk family member.
Validation of Plk1-dependent Phosphorylation Events
on Spindle Proteins through a Candidate-based in non cap-
ital Vitro Screen—As a consequence of reduced Plk1 activity,
phosphorylation sites on direct Plk1 substrates are expected
to be down-regulated in Plk1-depleted or TAL-treated cells.
However, considering that kinases and phosphatases often
FIG. 3. Plk1-dependent substrates. A, pie chart depicting proteins with down-regulated phosphorylation sites upon Plk1 inactivation.
Proteins are classified according to function and localization. Known Plk1 substrates are shown in bold. B, Venn diagram illustrating the overlap
between down-regulated phosphorylation sites (Class I) identified by shRNA and inhibitor experiments on spindle proteins. C, pie chart
depicting the regulation of phosphorylation sites on spindle proteins upon Plk1 inhibition/depletion. Sites were classified according to whether
they were down-regulated, unchanged, or not found in shPlk1- and/or TAL-treated cells. D–G, subnetworks generated using the STRING
database (78) with all proteins containing down-regulated phosphorylation sites upon Plk1 inactivation (see supplemental Fig. S5 for complete
interaction network). D and E, centrosomal and KT-NUP subnetworks identified only upon TAL treatment. F and G, ribosome-binding protein
subnetworks. A medium confidence setting (0.400) was used, and only experimental information (pink) or information from databases (light
blue) was used. APC/C, anaphase-promoting complex/cyclosome.
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FIG. 4. Validation of Plk1 phosphorylation sites. A, schematic representing direct and indirect consequences of Plk1 inhibition. B, example
of the in vitro approach to validate Plk1 phosphorylation sites. C, examples of phosphorylation sites on validated Plk1 substrates. Shown are
(from left to right) peptide spots (phosphoacceptor (S/T) to the left; alanine substitution (A) to the right), protein name, phosphorylated residue,
and target peptide. Phosphoacceptor residues are marked in red, 2 positions are marked in green, and hydrophobic residues at 1 position
are marked in blue. D, table summarizing in vitro results on the number of down-regulated phosphorylation sites on spindle proteins. Only the
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form complex signaling networks, the pool of regulated phos-
phorylation sites is also expected to include indirect targets of
Plk1 activity, notably proteins that are targets of kinases or
phosphatases that act downstream of Plk1 (Fig. 4A). Only
17% of the down-regulated sites on spindle proteins con-
formed to the previously described Plk1 consensus motif
(D/E)X(S/T) (13), whereas 14 and 15%matched the consensus
motifs for Cdk1 and Aurora A/B, respectively (Fig. 4F). To
distinguish direct from indirect substrates of Plk1 activity, we
adopted a peptide phosphorylation approach to validate po-
tential direct Plk1 target sites. Using peptides synthesized
directly on cellulose membranes as substrates, we performed
in vitro Plk1 kinase assays with recombinant Plk1 purified
from insect cells (Figs. 1G and 4B). The 358 down-regulated
sites identified on spindle components were arrayed on the
membrane as 12-mer peptides with the potential phosphoac-
ceptor amino acid kept constant at position 7 in either its
serine/threonine/tyrosine native form or changed to alanine to
verify signal specificity (Fig. 4B). Incubation of duplicate pep-
tide arrays (generated simultaneously) with either kinase and
[32P]ATP or [32P]ATP alone followed by extensive washing
resulted in clear and specific signals on membranes phos-
phorylated by Plk1, whereas only a few spots were detected
on control membranes incubated with [32P]ATP alone (Fig. 4,
B and C, and supplemental Fig. S6A) (see “Experimental
Procedures”). In total, 102 down-regulated sites could be
phosphorylated in vitro by Plk1 using this approach (Table I
and supplemental Table S3, A and B; see also Fig. 4C for
examples). More than 60% of these sites appeared to be
conserved in at least three (human and two other) species
selected for comparison, indicating that many of the detected
phosphorylation sites may be functionally relevant (Table I
and supplemental Table S3, A and B). Indeed, functionally
relevant residues recently shown to be phosphorylated by
Plk1, such as Ser-170 on MgcRacGAP (48), scored positive
using this approach (Table I).
Of the phosphorylation sites that were down-regulated in
vivo regardless of the strategy used for Plk1 inactivation, 44%
scored positive in the in vitro kinase assay. A similar propor-
tion of sites responding to Plk1 shRNA could be validated (28
or 46%, depending on whether sites were unchanged or not
found upon TAL treatment, respectively; Fig. 4D). In contrast,
of the sites responding exclusively to TAL, only 18 or 19%
(unchanged or not found upon shPlk1, respectively) scored
positive in the in vitro assay (Fig. 4D). Taken at face value, this
indicates that strong and rapid inactivation of Plk1 by TAL is
more likely to reveal indirect effects than the relatively slow
and incomplete inactivation achieved by shRNA.
Reconsideration of Plk1 Consensus Motif—Analysis of the
in vitro validated Plk1 sites using Motif-X (79) revealed that the
previously proposed Plk1 kinase consensus motif (D/E)X(S/
T)
 (where X is any amino acid and 
 is a hydrophobic amino
acid) (13) applies to only a subset of validated substrates (Fig.
4, C and F, and supplemental Table S3A). Although 56% of
peptides conforming to this consensus scored positive in the
in vitro kinase assay, similarly high success rates were ob-
served for peptides that carry an asparagine (Asn) or gluta-
mine (Gln) at position 2 (Fig. 4F, supplemental Table S3A,
and supplemental Experimental Procedures for statistics).
Furthermore, Asn at position 2 was also overrepresented in
the Motif-X analysis (Fig. 4E), consistent with the frequent
identification of corresponding peptides in our data set as well
as previous reports of Asn at the 2 position in substrates of
Plk1 (or its yeast homolog Cdc5p) in the literature, including
the anaphase-promoting complex/cyclosome subunit Cdc27
(49), the cohesion subunit Rec8 (50), the cytokinesis effector
kinase Rock2 (10), and the centralspindlin complex compo-
nent MgcRacGAP (48). To further explore the optimal Plk1
consensus motif, we used peptide arrays to examine the
tolerance of Plk1 for different amino acids at several positions
relative to the phosphoacceptor residue. Specifically, we
chose the sequence surrounding CENP-F Ser-1324 as it con-
tained an Asn in the 2 position, conformed well to the
Motif-X consensus, and was clearly down-regulated in both
the Plk1 shRNA and Plk1 inhibitor studies (Fig. 4G and
supplemental Table S3A). Using this peptide as a starting
point, each residue from positions 4 to 2 was substituted
with every other natural amino acid, and the ability of Plk1 to
phosphorylate the resulting peptides was analyzed in an in
vitro phosphorylation assay (Fig. 4G). Incubating a duplicate
control membrane with [32P]ATP in the absence of Plk1 re-
sulted in virtually no signal (supplemental Fig. S6B). In the
context of this peptide, our results demonstrate a strong
preference of Plk1 for particular residues N-terminal to the
phosphoacceptor amino acid. In contrast, most amino acid
substitutions were well tolerated at the 1 and 2 position,
although there was also a clear preference for hydrophobic
residues. One notable exception was proline at the 1 posi-
tion (Fig. 4G), which was not tolerated. This strongly suggests
that (S/T)P motifs are not substrates for Plk1. Furthermore, we
again find marked preferences for Asn or Glu at the 2
position, whereas Asp was not strongly preferred over
differences between the percentage of positive sites responding exclusively to TAL (18 or 19%) and down-regulated in both strategies (44%)
were statistically significant (Fisher’s test, p value 0.05). E, Motif-X analysis of validated Plk1 phosphorylation sites on spindle proteins. F,
schematic showing the number of identified and validated down-regulated sites on spindle proteins, displayed according to different motifs.
G, permutational analysis for Plk1 phosphorylation on the CENP-F peptide containing Ser-1324; residues at positions 4 to 2 were
substituted by every other amino acid. Red squares mark the positions of the original amino acid in the peptide; S and A refer to peptides with
the original amino acid acceptor or the alanine substitution.
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other residues, and, within the context of this particular
peptide, Gln was not well tolerated (Fig. 4G). This clearly
shows that Glu/Asp/Asn/Gln are not interchangeable in all
Plk1 substrate peptides. According to a similar analysis per-
formed on six different peptides carrying an Asn at the 2
position, we conclude that some peptides accept Glu/Asp but
not Gln, whereas others accept Gln but not Glu/Asp
(supplemental Fig. S7). Significantly, a leucine in position 3
was prominent in many validated phosphopeptides (Fig. 4, C
and G, and supplemental Table S3A), and substitution of this
residue was poorly accepted in the permutation analysis per-
formed on the CENP-F peptide (Fig. 4G). Collectively, these
observations are in agreement with both our MS data and the
results of the in vitro peptide phosphorylation analyses, and
they prompt us to propose that the consensus sequence for
Plk1 can be broadened to L(
)(E/N/D(Q))X(S/T)L(
). We em-
phasize, however, that even this broadened consensus does
not account for all observed Plk1 substrates.
Plk1-dependent Localization of Spindle Components—In
accordance with the requirement for Plk1 activity to properly
localize some of its substrates on the mitotic spindle (5), we
considered it possible that the localization of some downstream
targets would be altered as a consequence of Plk1 inhibition. To
analyze this possibility in a systematic and quantitative manner,
we treated cells with either TAL or MA, mixed the samples, and
then determined protein ratios for spindle preparations as well
as total lysates from identically treated cells (supple-
mental Table S4A; see also supplemental Table S4, B and C, for
MaxQuant protein identification output from spindle and lysates
experiments, respectively, and “Experimental Procedures”).
Proteins showing reduced or increased association with the
spindle apparatus are displayed in Fig. 5A (note that only pro-
teins with SILAC ratios identified in both spindle and total lysate
experiments are shown). Interestingly, many proteins that
showed down-regulated phosphorylation sites upon Plk1 inac-
tivation were also depleted from the spindle (Fig. 3A and
supplemental Table S3, A and B), arguing strongly that Plk1
activity is required for their spindle association.
An intriguing case was CENP-F, a large coiled coil protein
that transiently localizes to outer KTs and preferentially to KTs
of unaligned chromosomes (51). Although it was previously
TABLE I
Validated Plk1 phosphorylation sites on known spindle proteins
Known Plk1 substrates and Plk1 phosphorylation site are marked in
italic, and conserved sites are marked in bold (species are specified in
supplemental Table S3A, column P).
Proteins Accessionnumber Phosphorylation sites
ARHGEF2 Q92974 Ser-737




BLM P54132 Ser-26,a Ser-28a
Borealin Q53HL2 Ser-180
BUB1 O43683 Ser-661
CASC5 Q8NG31 Ser-1013, Ser-1808
CDC27 P30260 Ser-441
CENP-B P07199 Ser-306, Ser-307
CENP-C Q03188 Ser-96, Ser-104, Ser-110,
Thr-516, Ser-250, Thr-734
CENP-E Q02224 Ser-611, Ser-612





CENP-J (CPAP) Q9HC77 Ser-556a
CENP-L Q8N0S6 Ser-53
CENP-N Q96H22 Ser-226, Ser-235, Ser-282
CENP-T Q96BT3 Ser-45
CENPU (PBIP1) Q71F23 Ser-194




CDK5 (Cep215) Q96SN8 Ser-613, Ser-1102
Cep350 Q5VT06 Ser-2689
DGL7 (HURP) Q86T11 Ser-777
ERCC6L (PICH) Q2NKX8 Ser-774, Ser-790
INCENP Q9NQS7 Ser-72, Ser-330
KIF18A Q8NI77 Ser-681a
KIF20A O95235 Tyr-558, Ser-635
KIF23 Q02241 Ser-867,a Thr-897, Ser-889
KIFC1 (HSET) Q9BW19 Ser-33
KIF4A O95239 Ser-394, Ser-815,
LB1 Q8WWK9 Ser-533
MAD1 Q9Y6D9 Ser-8,a Ser-490a
NCAPD3 P42695 Thr-430, Ser-508







NUP107 P57740 Ser-4, Ser-57
NUP153 P49790 Ser-343
PCM1 Q15154 Ser-110
PCNT O95613 Ser-813, Ser-815, Thr-1688,
Thr-1690, Ser-2594,
Thr-3325, Ser-3326
PRC1 O43663 Ser-554, Ser-592
RACGAP1 Q9H0H5 Ser-164, Ser-170, Ser-214
SGOL2 O562F6 Ser-436, Ser-1151a
SON P18583 Ser-154
SPAG5 (ASTRIN) Q96R06 Ser-401




Proteins Accessionnumber Phosphorylation sites
TPX2 Q9ULW0 Ser-356, Thr-361, Ser-654
TUBA1C Q9BQE3 Ser-41, Ser-48
TUBGCP5 Q96RT8 Ser-182




a Sites that were identified with high confidence in earlier experi-
ments (analyzed with MSQuant) but only reached a final MASCOT
score 12 in this study (and hence were not included in
supplemental Table S3A).
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shown that CENP-F exhibits slower electrophoretic mobility
upon mitotic entry (52), little is known about CENP-F phos-
phorylation. We identified 19 serine and threonine phosphor-
ylation sites on CENP-F that were suppressed by more than
2-fold upon Plk1 inhibition, eight of which we could validate in
vitro (Table I and supplemental Table S3, A and B). Our MS
data further suggest that the levels of CENP-F on the spindle
apparatus were reduced upon Plk1 inactivation when com-
pared with the corresponding levels in total lysates (Fig. 5,
A–C, and supplemental Table S4A). In agreement with this
observation, immunofluorescence analysis revealed a signifi-
cant reduction of total CENP-F and CENP-F Ser-1324 phos-
phorylation signal at KTs upon TAL treatment (Fig. 5, D–F).
Phosphorylation at Ser-1324 was monitored using a phos-
phospecific antibody generated toward this residue (see
supplemental Fig. S8 for antibody characterization and spec-
ificity). These data demonstrate that CENP-F is a likely Plk1
target and that CENP-F localization is regulated by Plk1. In
addition, they confirm in vivo phosphorylation by Plk1 of sites
conforming to the broadened consensus motif defined above.
FIG. 5. Plk1-dependent localization
of spindle components. A, proteins are
arranged according to the effect of Plk1
inactivation on their association with the
spindle. Ratio of 1 indicates no change on
spindle levels relative to amounts in total
lysate (see supplemental information and
supplemental Table S4). B and C, repre-
sentative MS spectra of a CENP-F phos-
phopeptide quantified from spindles (B)
and total lysates (C) of MA/TAL-treated
cells. D, HeLa S3 cells treated with MA
or TAL were fixed and immunostained
for Ser(P)-1324 CENP-F (red), CENP-F
(green), and CREST (far red; depicted in
blue). DNA was visualized using DAPI
(blue). Scale bars, 10 m. E and F, fluo-
rescence intensity of Ser(P)-1324
CENP-F and total CENP-F, respectively,
was quantified on KTs in MA- or TAL-
treated cells. Intensities were plotted af-
ter normalization for CREST staining (10
cells/10 KTs per cell, n  3 indepen-
dent experiments). Columns and error
bars show average and S.D., setting a
ratio of 1 for MA-treated samples.
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Consequences of Plk1 Inactivation on Centrosomal Sub-
strates—Plk1 inhibition reduces the amounts of Plk1 associ-
ated with centrosomes (21, 35). Although centrosomes dis-
play functionality even after disruption of the centrosomal
localization of this kinase (53, 54), the recruitment of Plk1-de-
pendent centrosomal components is expected to be im-
paired. Strikingly, levels of pericentrin and Cep192 were
clearly attenuated in the spindle preparations upon TAL treat-
ment (Fig. 5A). In addition, we observed decreased Cep215
levels on the spindles of Plk1-inactivated cells (although we
failed to detect Cep215 in total cell lysates for normalization)
(supplemental Table S4A). We also identified and validated
several phosphorylation sites on pericentrin, Cep192, and
Cep215 (Table I) and confirmed by immunofluorescence anal-
ysis that all three proteins revealed defective centrosome
accumulation upon Plk1 inactivation (supplemental Fig.
S9, A–C; see also Ref. 55). In contrast, the localization of
another centrosomal protein, Cep135, that did not display
down-regulated phosphorylation sites and hence served as a
control was indistinguishable between DMSO- (control), MA-,
TAL-, or MA  TAL-treated cells (supplemental Fig. S9D).
These data strongly argue that pericentrin, Cep192, and
Cep215 are novel Plk1 substrates, and they support an inde-
pendent study identifying these proteins as Plk1-regulated
components involved in the recruitment of -Tubulin com-
plexes to mitotic centrosomes (55).
Integration of Aurora A and Plk1 Activity—Aurora A local-
ization to centrosomes has recently been shown to depend on
Plk1 activity (21, 53, 56). In agreement with this observation,
our MS data show that Aurora A levels on the isolated spindle
were reduced by 46% upon Plk1 inhibition when normalized
against total lysates (Figs. 5A and 6, A and B). It has also
recently been postulated that Plk1 contributes to efficient
Aurora A activation (57, 58). Indeed, compared with immuno-
precipitates from control (Eg5-inhibited) cells, both Plk1 and
Aurora A showed reduced in vitro kinase activity when immu-
noprecipitated from Plk1-inhibited cells (Fig. 6, C–E). Although
the reduction in activity was expected for Plk1, the significant
reduction in activity observed in parallel for Aurora A is con-
sistent with the notion that inhibition of Plk1 also reduces
Aurora A activity. In further support of the above conclusion,
we emphasize that several of the 358 phosphorylation sites
identified as down-regulated after Plk1 depletion/inhibition by
MS analysis conform to the Aurora A/B consensus motif (Fig.
FIG. 6. Reduced Aurora A activity as
consequence of Plk1 inactivation. A
and B, representative MS spectra of an
Aurora A peptide quantified from spin-
dles (A) and total lysates (B) of MA/TAL-
treated cells. C–E, Western blotting for
the indicated proteins in cell lysates from
MA/TAL-treated (left panels) or shEg5/
shPlk1 cells (right panels) (C). In vitro
kinase assays using Plk1 (D) or Aurora A
(Aur A) (E) are shown. Kinases were im-
munoprecipitated from MA/TAL-treated
or shEg5/shPlk1-induced cells, and ca-
sein (D) and myelin basic protein (MBP)
(E) were used as substrates. Protein
phosphorylation was visualized by auto-
radiography of 32P. Immunoprecipitates
(D and E) were probed by Western blot-
ting for the indicated proteins (F). Phos-
phorylation sites on Aurora A substrates
were validated by in vitro kinase assays
on peptide arrays as described in the
legend to Fig. 4C.
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4F) (59, 60). Interestingly, many of these sites were present in
proteins likely to be Aurora A substrates, including known
Aurora A interactors, such as TPX2 (61) or centrosomal pro-
teins and MAPs involved in centrosome maturation and spin-
dle assembly (supplemental Table S3C). To corroborate a
direct role of Aurora A in the phosphorylation of these sub-
strates, Aurora A kinase assays were performed in vitro on
peptide arrays in the same manner as described above for
Plk1. Included in this assay were all phosphopeptides that (i)
were down-regulated upon Plk1 inactivation but negative in
the Plk1 in vitro assays, (ii) conformed to an Aurora consen-
sus motif, and (iii) were potential Aurora A substrates ac-
cording to their reported function and localization (see
supplemental Table S3C). These experiments revealed six
novel candidate Aurora A substrates and 11 new Aurora A
phosphorylation sites (Fig. 6F and Table II). Collectively, the
data support the idea that Aurora A is an important down-
stream effector of Plk1 activity.
DISCUSSION
Phosphoproteomics has emerged as a powerful approach
for the study of complex regulatory networks (19, 62–64). In
addition to providing comprehensive inventories of phosphor-
ylation sites, proteomics approaches based on either isotope
labeling techniques or label-free quantitation methods offer
the opportunity for studying quantitative aspects of intracel-
lular signaling. In this study, we deployed quantitative pro-
teomics methods in conjunction with the inhibition of Plk1, a
major regulatory kinase known to be essential for cell cycle
progression through mitosis. Our data provide insight into the
phosphoproteome that is controlled, directly or indirectly, by
Plk1. Furthermore, we used in vitro peptide spotting assays
and recombinant Plk1 for in vitro phosphorylation analysis to
validate many of the potential Plk1 target sites inferred from
our quantitative proteomics data set. These latter results led
us to propose that physiological Plk1 target sites conform to
a broader consensus sequence than hitherto recognized.
Complementary Strategies to Explore the Plk1-dependent
Phosphoproteome—Despite the increased understanding of
Plk1 function in recent years (4–6, 65), many of its physiolog-
ical functions cannot be explained by the substrates identified
to date. Here, we used a combination of approaches to ex-
tend our knowledge of Plk1 signaling. Through the isolation of
the spindle apparatus prior to analysis by mass spectrometry,
we were able to focus our study specifically on Plk1 targets
and phosphorylation events related to mitotic centrosomes,
spindle poles, and spindle-associated proteins. This ap-
proach, in combination with an efficient TiO2-based phos-
phopeptide enrichment protocol and high resolution orbitrap
mass spectrometry, allowed for the detection and SILAC-
based quantitation of almost 4000 phosphorylation sites. Be-
cause protein phosphorylation states often regulate spindle
localization, it was important to normalize all phosphorylation
ratios to the corresponding changes in protein levels. In this
context, the prior reduction in sample complexity by spindle
isolation was crucial for recovering sufficient numbers of un-
phosphorylated peptides (from non-TiO2 enriched samples)
for normalization to protein levels. Of particular importance,
we used two different but complementary experimental strat-
egies for identification of Plk1 targets, namely inhibition of
kinase activity by the small molecule inhibitor TAL and deple-
tion of endogenous Plk1 through use of a stable inducible
shRNA cell line. Collectively, we identified many previously
uncharacterized downstream targets and new Plk1-specific in
vivo phosphorylation sites, many of which could be validated
in vitro.
Although 52% of the total 3894 phosphorylation sites could
be identified through both experimental strategies, the phos-
phorylation sites identified in biological replicates of TAL in-
hibition or shPlk1 depletion experiments revealed 38 and 32%
overlap, respectively (supplemental Fig. S2A). These variabil-
ities may be explained in part by differences in spindle purity
and variability during the phosphoenrichment process and
MS procedure. In addition, they are likely to reflect differences
in the efficiency and/or kinetics of Plk1 inactivation in re-
sponse to the two strategies (inhibition versus depletion). It is
striking that many more Plk1-dependent sites were found to
be regulated in response to TAL treatment than shPlk1-me-
diated depletion. Likewise, the extent of down-regulation was
often more pronounced in the former case. Only 13% of all
sites could be shown to be down-regulated in both ap-
proaches (supplemental Fig. S2B). This low degree of overlap
may appear surprising, but we emphasize that both exper-
imental and biological reasons concur to reduce this num-
ber (for a review, see Ref. 66). On the experimental side,
shRNA is not expected to be sufficiently effective to reveal
down-regulation of all phosphopeptides over the time
course of the experiment; conversely, TAL treatment is likely
to have been so efficient that in some cases no residual
phosphopeptide was available for determination of a SILAC
ratio. From the biological perspective, several reasons
might explain regulation observed upon TAL treatment but
not after shRNA-mediated depletion. First, we note that
more putative Cdk1 and Aurora A substrates were found to
TABLE II
Validated Aurora A phosphorylation sites on known spindle proteins







KIF11 (Eg5) P52732 Ser-931
PCNT O95613 Ser-1653, Ser-2044, Ser-2860
SON P18583 Ser-2020
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be affected by TAL treatment than by shPlk1, whereas in
vitro validation of putative Plk1 targets revealed a smaller
percentage of positive hits in the case of TAL-responsive
sites. This suggests that rapid and thorough inhibition of
Plk1 by TAL facilitates the detection of indirect downstream
targets. Second, it is possible that some TAL-sensitive
phosphorylation sites reflect the action of Plk2, Plk3, or
unknown protein kinases, although the latter is unlikely (21).
Third, some high affinity Plk1 sites may show only minor
down-regulation in response to TAL, particularly if phospha-
tases fail to remove the corresponding phosphates within
the time frame of our experiments. Finally and most inter-
estingly, we note that some phosphopeptides were down-
regulated only in response to shPlk1 but not TAL treatment.
Taken at face value, phosphorylation of these peptides
would thus seem to depend on the presence of Plk1 protein
rather than Plk1 activity. However, this conclusion suffers
from the caveat that this latter class of phosphopeptides
also includes sites for which no SILAC pair could be iden-
tified in the TAL experiments.
A priori, it could be argued that some of the observed
changes in phosphorylation levels might reflect increased
phosphorylation in response to Eg5 inactivation (in the sam-
ples analyzed for control) rather than decreased phosphory-
lation upon Plk1 inactivation. It is formally possible that Eg5
depletion or inhibition affects the activity of kinases and/or the
availability of substrates, but at present, no such effects are
described in the literature. We measured the in vitro activities
of several mitotic kinases, notably Plk1, Aurora A, Aurora B,
Cdk1, and Nek2, and found none of these to be affected by
Eg5 depletion or inhibition (shown for Plk1 in Fig. 2H; not
shown for the other kinases). Likewise, we showed that Plk1
localization is not affected by Eg5 depletion or inhibition (Fig.
2G). Furthermore, label-free quantitation revealed strong cor-
relation of the regulation of sites responding to TAL treatment
alone with that seen upon combined MA  TAL treatment,
indicating that the bulk of regulation is due to Plk1 inhibition
(and not up-regulation in response to Eg5 inhibition;
supplemental Fig. S1C). Most importantly, many of the puta-
tive Plk1-regulated phosphorylation events were subse-
quently validated by in vitro kinase assays. Thus, although we
cannot rigorously exclude that a few of the described sub-
strates are actually hyperphosphorylated in response to Eg5
inactivation (rather than dephosphorylated upon Plk1 inacti-
vation), we are confident that this explanation cannot possibly
account for the bulk of the results.
Validation of Putative Plk1 Spindle Targets and Broadening
of Plk1 Consensus Motif—Our analysis revealed 358 phos-
phorylation sites on spindle proteins that were down-regu-
lated upon Plk1 inhibition/depletion, but surprisingly, only
17% of these sites matched the classical Plk1 consensus
motif ((E/D)X(pS/T)) (13). A study combining peptide arrays
with in vitro kinase assays led us to propose a broadened
consensus that also favors Leu at position3 and allows Asn or
Gln at position2. Although this broadened consensus accom-
modates many more peptides scoring positive for in vitro phos-
phorylation by Plk1, we emphasize that in vivo specificity of Plk1
is certainly influenced by parameters that cannot be repre-
sented in a linear recognition motif. Another interesting feature
emerging from a global analysis of the proteins containing val-
idated Plk1 phosphorylation sites is that 30% of these did not
contain a PBD recognition motif conforming to the consensus
S(pS/T)P. This suggests that a third of all Plk1 substrates involve
Plk1 docking through sites either that are primed by kinases
other than Cdk1 or that are not primed at all.
Plk1 Regulation of Centrosome-associated Proteins—In
agreement with a role of Plk1 in spindle assembly and func-
tion, many proteins appeared to be mislocalized from the
spindle upon Plk1 inactivation. This may reflect a direct reg-
ulation by phosphorylation or may be an indirect effect of the
role of Plk1 in controlling spindle dynamics (67). For example,
we observed a reduction of spindle-associated KIF2A upon
Plk1 inactivation in agreement with a recent report (68). Fur-
thermore, we found that subunits of the -Tubulin ring com-
plex as well as proteins implicated in -Tubulin recruitment to
the centrosome (the centrosomal proteins pericentrin,
Cep192, and Cep215 (55)) were also lost from spindles upon
Plk1 inhibition. One striking example for cooperation between
mitotic kinases may be seen at the G2 to M transition when
Plk1 cooperates with Aurora A to induce centrosome matu-
ration (4, 6, 69). In particular, it has recently been proposed
that Plk1 regulates Aurora A activity and vice versa (57, 58, 70,
71). Here we identified a subset of phosphorylation sites that
showed down-regulation upon Plk1 inhibition but conformed
to Aurora A sites and, moreover, could readily be phosphor-
ylated by Aurora A in vitro. These results lend strong support
to the proposal that the role Plk1 in centrosome maturation
may be explained, at least in part, by its impact on Aurora A
localization and activity (57). We also identified substrates
common to both Plk1 and Aurora A, such as pericentrin, the
-Tubulin subunit GCP2, and the centrosomal protein
Cep215, confirming that these two kinases cooperate to con-
trol key early mitotic functions through co-regulation of sev-
eral important substrates.
Plk1 Regulation of Kinetochore Proteins—We identified
novel phosphorylation sites down-regulated after Plk1 inhibi-
tion on INCENP, Bub1, Hec1, and PIBP1 (also known as
CENP-U (9)). Plk1-dependent phosphorylation of these sub-
strates would be consistent with a role of these proteins in
targeting Plk1 to KTs; in addition, however, they may play an
important role in regulating KT functions independently of
Plk1 recruitment. Once Plk1 is bound to KTs, little is known
about key Plk1 substrates at this site. We identified down-
regulated sites upon Plk1 inactivation on proteins known to
contribute to the establishment and/or maintenance of KT-MT
interactions (such as the KNL-1/Mis12 complex/Ndc80 com-
plex (KMN) network and Ska components; see Fig. 3A) (1). In
addition, we validated phosphorylation sites sensitive to Plk1
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inhibition on CENP-F and CENP-E, both of which are required
for proper chromosome congression. Our MS analysis also
revealed reduced Mad1/Mad2 levels on the spindle as well as
down-regulated phosphorylation sites on Mad1 upon Plk1
inactivation. Although Plk1 is not essential for the spindle
assembly checkpoint in somatic cells (5), decreased levels of
Mad1 and Mad2 at the kinetochores have been previously
reported upon Plk1 depletion (9, 72). Our results are in agree-
ment with these findings and suggest a possible role of Plk1
in fine tuning the localization of several checkpoint compo-
nents. Collectively, our study reveals several novel Plk1-de-
pendent phosphorylation events that are likely to contribute to
control centrosome maturation, spindle assembly, and kine-
tochore function.
Novel Plk1-regulated Components of Spindle?—Interest-
ingly, a number of NPC components, including several
nucleoporins (NUPs), were also identified as putative Plk1
substrates. It is possible that members of the NUP family are
regulated by Plk1, perhaps controlling complex formation or
KT localization after nuclear envelope breakdown (45). NPC
proteins, notably the Nup107–160 complex, have recently
been implicated in microtubule nucleation from KTs (73) and
in the regulation of complex formation between the translo-
cated promoter region and the spindle assembly checkpoint
components Mad1 and Mad2 (74). A subset of ribosome-
associated and RNA-binding proteins was also enriched
among the putative Plk1 substrates. Whether the presence of
these proteins in our spindle preparations (see also Ref. 16)
reflects contamination or a genuine spindle association re-
mains to be clarified. In support of a physiological role of
RNA-binding proteins in the spindle, we note that conserved
classes of mRNA were found to be enriched on this structure
(75), and PRPF4, a protein kinase implicated in the regulation
of mRNA splicing (also identified in our data set), has been
shown to localize to KTs during mitosis (76). It is tempting,
therefore, to speculate that Plk1 activity contributes to the
association of these proteins with the spindle apparatus per-
haps to ensure their proper segregation during cell division.
Another possibility is that Plk1 contributes to suppress cap-
dependent translation and/or enhance cap-independent
translation during mitosis (77). In support of this latter notion,
we observed down-regulation of phosphorylation sites on two
members of the eIF4F complex upon Plk1 inhibition.
In summary, our comprehensive study of phosphoregula-
tion by Plk1 vastly extends the inventories of direct Plk1
substrates, Plk1-dependent phosphorylation sites on the mi-
totic spindle apparatus, and downstream effectors of Plk1 in
mammalian cells. These data should thus serve as a valuable
resource for future research in the field. The strategies devel-
oped here for the analysis of the Plk1-dependent proteome
and phosphoproteome on the mitotic spindle can in principle
be applied to other protein kinases provided that effective
shRNA duplexes and/or specific inhibitors are available.
These strategies thus respond to a growing contemporary
need for assigning experimental phosphoproteome data sets
to specific individual kinases.
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